These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 30626228

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anti-N and anti-Doa immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC-201: case report and review of the literature.
    Unnikrishnan A, Pelletier JPR, Bari S, Zumberg M, Shahmohamadi A, Spiess BD, Michael MJ, Harris N, Harrell D, Mandernach MW.
    Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.
    Uhlmann EJ, Shenoy S, Goodnough LT.
    Transfusion; 2014 Feb; 54(2):384-8. PubMed ID: 23692505
    [Abstract] [Full Text] [Related]

  • 7. Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab.
    Lee LE, Beeler BW, Graham BC, Cap AP, Win N, Chen F.
    Transfusion; 2020 Jan; 60(1):30-35. PubMed ID: 31642065
    [Abstract] [Full Text] [Related]

  • 8. Complement activation during intravascular hemolysis: Implication for sickle cell disease and hemolytic transfusion reactions.
    Merle NS, Boudhabhay I, Leon J, Fremeaux-Bacchi V, Roumenina LT.
    Transfus Clin Biol; 2019 May; 26(2):116-124. PubMed ID: 30879901
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single-center case series.
    Lapite A, Bhar S, Fasipe T.
    Pediatr Blood Cancer; 2024 Aug; 71(8):e31061. PubMed ID: 38840429
    [Abstract] [Full Text] [Related]

  • 11. Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.
    Narbey D, Habibi A, Chadebech P, Mekontso-Dessap A, Khellaf M, Lelièvre JD, Godeau B, Michel M, Galactéros F, Djoudi R, Bartolucci P, Pirenne F.
    Am J Hematol; 2017 Dec; 92(12):1340-1348. PubMed ID: 28924974
    [Abstract] [Full Text] [Related]

  • 12. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Balbuena-Merle R, Hendrickson JE.
    Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.
    Vidler JB, Gardner K, Amenyah K, Mijovic A, Thein SL.
    Br J Haematol; 2015 Jun; 169(5):746-53. PubMed ID: 25753472
    [Abstract] [Full Text] [Related]

  • 15. Delayed Severe Hemolytic Transfusion Reaction During Pregnancy in a Woman with β-Thalassemia Intermediate: Successful Outcome After Eculizumab Administration.
    Cannas G, Dubreuil L, Fichez A, Gerfaud-Valentin M, Debard AL, Hot A.
    Am J Case Rep; 2021 May 13; 22():e931107. PubMed ID: 33983909
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Delayed hemolytic reaction to transfusion in sickle cell anemia. Report of one case].
    Moya F, Rivera M, Araya F, Donoso J, Sandoval P, Varas P.
    Rev Med Chil; 2018 Nov 13; 146(11):1347-1350. PubMed ID: 30725050
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Urgent use of voxelotor in sickle cell disease when immediate transfusion is not safe.
    Ferlis M, Lipato T, Roseff SD, Smith WR.
    Eur J Haematol; 2022 Nov 13; 109(5):586-589. PubMed ID: 35848827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.